U.S. markets open in 47 minutes

HeartCore Enterprises, Inc. (HTCR)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
1.1300+0.0300 (+2.73%)
At close: 03:57PM EST
1.1000 -0.03 (-2.65%)
Pre-Market: 04:54AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected


Previous Close1.1000
Bid1.0400 x 1000
Ask1.1600 x 800
Day's Range1.0917 - 1.1700
52 Week Range0.8090 - 6.1900
Avg. Volume689,736
Market Cap19.944M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for HTCR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Heartcore Enterprises, Inc.
    Daily – Vickers Top Insider Picks for 12/02/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
    Fair Value
    Economic Moat
    3 days agoArgus Research
View more
  • GlobeNewswire

    HeartCore Signs Fifth Go IPO Agreement with SBC Medical Group

    NEW YORK and TOKYO, Nov. 23, 2022 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (“HeartCore” or the “Company”), a leading software development company, announced that it has signed an agreement (“Consulting Agreement”) with SBC Medical Group, Inc. (“SBC Medical”), for its fifth Go IPO consulting service within an eight-month period. As part of the Consulting Agreement, HeartCore will assist SBC Medical in its efforts to go public and list on the Nasdaq Stock Market (“Nasdaq”). Through Go IPO,

  • GlobeNewswire

    HeartCore Reports Third Quarter 2022 Financial Results

    NEW YORK and TOKYO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (“HeartCore” or “the Company”), a leading software development company, today reported financial results for the third quarter ended September 30, 2022. Third Quarter 2022 and Recent Operational Highlights Grew total number of global enterprise customers to 889 as of September 30, 2022.HeartCore’s Content Management System (“CMS”) led Japan in CMS market share for the seventh straight year according to ITR Corporat


    Sidoti's November Micro-Cap Virtual Conference

    Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day November Micro-Cap Conference taking place Wednesday and Thursday, November 9-10, 2022.